107 related articles for article (PubMed ID: 1717780)
21. Rapid conversion of the new angiotensin converting enzyme inhibitor ramipril to its active metabolite in rats.
Tabata S; Yamazaki H; Ohtake Y; Hayashi S
Arzneimittelforschung; 1990 Aug; 40(8):865-7. PubMed ID: 2173610
[TBL] [Abstract][Full Text] [Related]
22. Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat.
Caspritz G; Alpermann HG; Schleyerbach R
Arzneimittelforschung; 1986 Nov; 36(11):1605-8. PubMed ID: 3028436
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation.
Wong J; Rauhöft C; Dilley RJ; Agrotis A; Jennings GL; Bobik A
Circulation; 1997 Sep; 96(5):1631-40. PubMed ID: 9315558
[TBL] [Abstract][Full Text] [Related]
24. Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats.
Gould AB; Goodman SA
Eur J Pharmacol; 1990 Jun; 181(3):225-34. PubMed ID: 2143478
[TBL] [Abstract][Full Text] [Related]
25. Effect of converting enzyme inhibitors on cardiac changes in experimental uremia.
Rambausek M; Mall G; Kollmar S; Ritz E
Kidney Int Suppl; 1988 Sep; 25():S201-3. PubMed ID: 2972864
[No Abstract] [Full Text] [Related]
26. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
Clauser E
Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
[TBL] [Abstract][Full Text] [Related]
27. Interference with the autonomic nervous system by the converting enzyme inhibitor ramipril in conscious spontaneously hypertensive rats.
Moursi M; el-Dakhakhny M; Schölkens BA; Unger T
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S125-8. PubMed ID: 2485046
[TBL] [Abstract][Full Text] [Related]
28. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production.
Ogawa T; Linz W; Stevenson M; Bruneau BG; Kuroski de Bold ML; Chen JH; Eid H; Schölkens BA; de Bold AJ
Circulation; 1996 Jun; 93(11):2059-67. PubMed ID: 8640983
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of perindopril, a novel angiotensin-converting enzyme inhibitor, on neointima formation after balloon injury in rats and cholesterol-fed rabbits.
Shibutani T; Kanda A; Ishigai Y; Mori T; Chiba K; Tanaka M; Tachizawa H
J Cardiovasc Pharmacol; 1994 Sep; 24(3):509-16. PubMed ID: 7799645
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
Ocón-Pujadas J; Debusmann ER; Jane F; Lahn W; Irmisch R; Mora J; Grötsch H
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S45-8. PubMed ID: 2474101
[TBL] [Abstract][Full Text] [Related]
31. Renin-angiotensin and vasopressin in the development of salt-induced hypertension.
Gavras I; Mulinari R; Gavras H
J Hypertens; 1988 Dec; 6(12):999-1002. PubMed ID: 2975694
[TBL] [Abstract][Full Text] [Related]
32. Baroreflex setting and sensitivity in normal subjects: effects of pharmacologic inhibition of the angiotensin I converting enzyme.
Düsing R; Kayser G; Wagner S; Scherf H; Glänzer K; Predel HG; Kramer HJ
Am J Cardiol; 1987 Apr; 59(10):50D-54D. PubMed ID: 3034033
[TBL] [Abstract][Full Text] [Related]
33. Effect of ramipril on the regulation of the expression of connexins 40 and 43 in a rabbit model of arterial balloon injury.
Li DQ; Chen WX; Zhou YP; Han Y
Mol Med Rep; 2012 Sep; 6(3):565-9. PubMed ID: 22711019
[TBL] [Abstract][Full Text] [Related]
34. Effect of angiotensin-converting enzyme inhibitor Hoe-498 on noradrenaline-induced vasoconstriction in isolated perfused mesentery of rats.
Xiang JZ; Schölkens BA
Zhongguo Yao Li Xue Bao; 1984 Jun; 5(2):104-5. PubMed ID: 6087609
[No Abstract] [Full Text] [Related]
35. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.
Powell JS; Clozel JP; Müller RK; Kuhn H; Hefti F; Hosang M; Baumgartner HR
Science; 1989 Jul; 245(4914):186-8. PubMed ID: 2526370
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronan and hyaluronectin production in injured rat thoracic aorta.
Chajara A; Levesque H; Courel MN; Chauzy C; Maingonnat C; Bertrand P; Delpech B
Atherosclerosis; 1996 Sep; 125(2):193-207. PubMed ID: 8842351
[TBL] [Abstract][Full Text] [Related]
37. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.
Linz W; Schölkens BA; Han YF
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S91-9. PubMed ID: 2438498
[TBL] [Abstract][Full Text] [Related]
39. Sympathetic nervous activity and noradrenaline reactivity during angiotensin converting enzyme inhibition.
Philipp T; Sharma AM; Thiede HM; Kribben A
Am J Cardiol; 1987 Apr; 59(10):55D-59D. PubMed ID: 3034034
[TBL] [Abstract][Full Text] [Related]
40. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
